Literature DB >> 6407363

Time course of ventilatory depression after thiopental and midazolam in normal subjects and in patients with chronic obstructive pulmonary disease.

J B Gross, M E Zebrowski, W D Carel, S Gardner, T C Smith.   

Abstract

Using a dual isohypercapnic technique, the authors compared the effect on ventilatory control of midazolam (0.2 mg/kg) and thiopental (3.5 mg/kg) in normal volunteers and in subjects with chronic obstructive pulmonary disease (COPD). In normal volunteers the slope of the CO2 response curve decreased from 1.77 +/- 0.16 l . min-1 . mmHg-1 (mean +/- SEM) to a minimum of 1.14 +/- 0.17 l . min-1 . mmHg-1 3.5 min after midazolam, returning to 1.32 +/- 0.21 l . min-1 . mmHg-1 15 min after injection. In the same subjects, the slope of the CO2 response curve fell from 1.89 +/- 0.18 l . min-1 . mmHg-1 to a minimum of 1.37 +/- 0.29 l . min-1 . mmHg-1 one minute after injection of thiopental, returning to 1.69 +/- 0.22 l . min-1 . mmHg-1 15 min after injection. These changes were not statistically significant. In subjects with clinical COPD, the slope of the CO2 response curve decreased from 1.89 +/- 0.63 l . min-1 . mmHg-1 to a minimum of 0.39 +/- 0.19 l . min-1 . mmHg-1 two minutes after injection of midazolam (P less than 0.05 compared with control), while 15 min after injection, the slope recovered to only 0.62 +/- 0.40 l . min-1 . mmHg-1 (P less than 0.05 compared with control). In the same subjects, the slope of the CO2 response curve decreased from 1.53 +/- 0.17 to a minimum of 0.69 +/- 0.25 l . min-1 . mmHg-1 0.5 min after injection of thiopental, recovering to 1.47 +/- 0.28 l . min-1 . mmHg-1 15 min after injection. This was significantly greater than the corresponding slope after midazolam (P less than 0.05). The authors conclude that while the time course of ventilatory depression after thiopental is similar in normal volunteers and in patients with COPD, the ventilatory depression 15 minutes after midazolam is more profound in patients with COPD than in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407363     DOI: 10.1097/00000542-198306000-00011

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

Review 1.  Adult sedation: oral, rectal, IM, IV.

Authors:  J A Giovannitti; L D Trapp
Journal:  Anesth Prog       Date:  1991 Jul-Oct

Review 2.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

3.  Daily titration of neurally adjusted ventilatory assist using the diaphragm electrical activity.

Authors:  Hadrien Rozé; Abdelghani Lafrikh; Virginie Perrier; Arnaud Germain; Antoine Dewitte; Francis Gomez; Gérard Janvier; Alexandre Ouattara
Journal:  Intensive Care Med       Date:  2011-03-22       Impact factor: 17.440

Review 4.  Midazolam: review of a versatile agent for use in dentistry.

Authors:  J A Giovannitti
Journal:  Anesth Prog       Date:  1987 Sep-Oct

Review 5.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 6.  Management of insomnia in patients with chronic obstructive pulmonary disease.

Authors:  Charles F P George; Charles D Bayliff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Adverse effects of general anaesthetics.

Authors:  M C Berthoud; C S Reilly
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 8.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

Review 9.  Effects of anaesthesia techniques and drugs on pulmonary function.

Authors:  Vijay Saraswat
Journal:  Indian J Anaesth       Date:  2015-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.